Effects of Combined Fluoxetine and Counseling in the Outpatient Treatment of Cocaine Abusers

References

• O'Brien C. P., Childress A. R., Arndt I. O., et al. Pharmacological and behavioral treatments of cocaine dependence: Controlled studies. J. Clin. Psychiatry 1988; 49: 17–22, 2, Suppl.
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D., Byck R., et al. Desipramine facilitation of initial cocaine abstinence. Arch. Gen. Psychiatry 1989; 46: 117–121
   PubMed Web of Science ®Google Scholar
• Levin F. R., Lehman A. F. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. J. Clin. Psychopharmacol. 1991; 11: 374–378
   PubMedGoogle Scholar
• Sellers E. M., Higgins G. A., Tomkins D. M., et al. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications. J. Clin. Psychiatry 1991; 52: 49–54, 12, Suppl.
   PubMed Web of Science ®Google Scholar
• Carroll M. E., Lac S. T., Asencio M., et al. Fluoxetine reduces intravenous cocaine self-administration in rats. Biochem. Behav. 1990; 35: 237–244
   PubMed Web of Science ®Google Scholar
• Porrino L. J., Ritz M. C, Goodman N. L., et al. Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 1989; 45: 1529–1535
   PubMed Web of Science ®Google Scholar
• Batki S. L., Manfredi L. B., Jacob HIP., et al. Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine/benzoylecgonine concentrations. J. Clin. Psychopharmacol. 1993; 13: 243–250
   PubMed Web of Science ®Google Scholar
• Gorelick D. A., Paredes A. Effects of fluoxetine on alcohol consumption in male alcoholics. Alcoholism Clin. Exp. Res. 1992; 16: 261–265
   PubMed Web of Science ®Google Scholar
• Gawin F. H. Cocaine addiction: Psychology and neurophysiology. Science 1991; 251: 1580–1586
   PubMed Web of Science ®Google Scholar
• Kosten T. R. Can cocaine craving be a medication development outcome? Drug craving and relapse in opioid and cocaine dependence. Am. J. Addict. 1992; 1: 230–239
   Google Scholar
• Kozlowski L. T., Mann R. E., Wilkinson D. A., et al. “Cravings” are ambiguous: Ask about urges or desires. Addict. Behav. 1989; 14: 443–445
   PubMed Web of Science ®Google Scholar
• Tiffany T. T. A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes. Psychol. Rev. 1990; 97: 147–168
   PubMed Web of Science ®Google Scholar
• McLellan A. T., Luborsky L., O'Brien C. P., et al. An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. J. Nerv. Ment. Dis. 1980; 168: 26–33
   PubMed Web of Science ®Google Scholar
• Derogatis L. K., Lipman R. S., Covi L. The SCL-90 An outpatient psychiatric rating scale. Psychopharmacol. Bull. 1973; 9: 23–28
   Google Scholar
• Blouin A. G., Perez E. I., Blouin J. H. Computerized administration of the Diagnostic Interview Schedule. Psychiatric Res 1988; 23: 335–344
   PubMed Web of Science ®Google Scholar
• Shipley W. C. Shipley Institute of Living Scale. Western Psychological Services, Los Angeles, California 1984
   Google Scholar
• McNair D. M., Lorr M. An analysis of mood in neurotics. J. Abnorm. Soc. Psychol. 1964; 69: 620–627
   PubMed Web of Science ®Google Scholar
• Rounsaville B. J., Gawin F. H., Kleber H. D. Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am. J. Drug Alcohol Abuse 1985; 11: 171–191
   PubMed Web of Science ®Google Scholar
• Covi L., Lipman R. S., Smith J. E., II. Group psychotherapy and pharmacotherapy of depression. Combined Pharmacotherapy and Psychotherapy, D. Manning, A. Frances. American Psychiatric Press, Washington, DC 1990
   Google Scholar
• Uhlenhuth E. H., Lipman R. S., Covi L. Combined pharmacotherapy and psychotherapy: Controlled studies. J. Nerv. Ment. Dis. 1969; 148: 52–64
   PubMedGoogle Scholar
• Fichter M. M., Leibl K., Rief W., et al. Fluoxetine versus placebo: A double-blind study with bulimia inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991; 24: 1–7
   PubMed Web of Science ®Google Scholar
• Beasley C. M., Jr., Bosomworth J. C, Wernicke J. F. Fluoxetine: Relationships among dose, response, adverse events and plasma concentration in the treatment of depression. Psychopharmacol. Bull. 1990; 26: 18–24
   PubMedGoogle Scholar
• Montoya I. D., Hess J. M., Covi L., et al. Comparative study of psychopathology and cognitive functions between cocaine and opiate dependent patients seeking treatment. Am. J. Addict., in press
   Google Scholar
• Montgomery S. A., Baldwin D., Shah A., et al. Plasma-level response relationships with fluoxetine and zimelidine. Clin. Psychopharmacol. 1990; 13: S71–S75, 1, Suppl.
   Google Scholar
• Tyrer S. P., Marshall E. F., Griffith H. W. The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990; 14: 797–805
   PubMedGoogle Scholar
• Norman T. R., Gupta R. K., Burrows G. D., et al. Relationship between antidepressant response and plasma concentration of fluoxetine and norfluoxetine. Int. Clin. Psychopharmacol. 1993; 8: 25–29
   PubMed Web of Science ®Google Scholar
• Covi L., Hess J. M., Kreiter N. A. Psychotherapy Dosage Effects on Cocaine Dependence. Presented at the American Psychiatric Association 146th Annual Meeting. 1993. San Francisco, California May 26, 1993
   Google Scholar